EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS020-04683 
Organism
Homo sapiens 
Tissue/cell
CD34+ 
Coordinate
chr1:246784940-246786070 
Target genes
Number: 7             
NameEnsembl ID
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Atoh1MA0461.2chr1:246785659-246785669AACATATGTT+6.02
Atoh1MA0461.2chr1:246785659-246785669AACATATGTT-6.02
NFICMA0161.2chr1:246785562-246785573TACTTGGCAGA+6.62
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1246785534246785836
Enhancer Sequence
TCTGGTAAAC CCTTCACTTT CAGCCTCACG AAAATTCCCC TAGCAGTGTT TGGAATGATC 60
TAAAATGCTG TCTTGGCTGG GCGCAGTGGC TCATGCCTGT AATCCCAGCA TTTTGGGAGG 120
CTGAGGTGGG TGGATGGCTT GAGCTCAGGA GTTCAAGACC AGCCTGGGCA ACATGGCGAA 180
ACCCCATCTC TACAAAATAT ACAAAAATTA GCCGGGCATG GTGGTGCACA CCTGTAGTCC 240
CAGCTACTTG GGAGGCCAAG GTGGGACGAT CACTCAAGCC TGGGAGGCAA AGGTTGCATT 300
GAGCTGACAT TGCACCACTG CACTCCAGCC TGGGAGACAG AGTGAGAGAA CCTGTCTCTA 360
AATACATAAA TAAATATAAA AATAAAAAAT AAAATGCAAT CTCTGTAAAA TTGACTGTGT 420
CCCACTCATC ACTGGTGAGC CCGGGGGAGG GTGACCCTCG TGGGATATTT GGCATATTAC 480
TAATTGATGG CCACATCTTG GCCTTGGCTA ATCCATAGTT TAAACAATGG TTCACTTTTT 540
AAATCAGTGA TAAAGCTGTG TAAGAGTTTG ATAAGCATCT ACCAGGCACC AAAGACCCTG 600
CTGGACATGG GTAAACAGAG ATTACTTGGC AGAATATGCC CGTAAGAGAG CCCCTGCAGA 660
ACAGGAGCAA CGGTTCTATC GATAAGTAAG TGTGGAATTT TGTGTTCAGT GTTAGAGTAA 720
ACATATGTTA AAGATTCAGC AGCACAAAAT GAGTGATTCA TTCTGCCCTG TGGACACTTG 780
GGAACAGAAG GCGACTCTTG AGCTGGGTTT TCCAGGCTTA TTAGGCGCTC AGTGGGTTAA 840
CAGAATGAGC TGGTCCAGGA AGAGATCAGC CTGTGAAAGC CGTGGCTGGG ATATTATTGG 900
AGATGAAGAT GTTAAAAGAG GAGGTGAGAT TGAATAGCTG GTGACATTGA GACTTTATTT 960
TTAGGGACTG GGAATTTTTA ATTCTAAGAG TGCCTGAATC ACATTTGCAT TTTAGAAGAA 1020
GAACTCTTTT GAGGATTGAG AGGGTGTAGA TGTTAGAGGA TGGAGAGGCT GGAGACTGGG 1080
GAGCCTTTAG GCCGGTGGTG AGGAAACTTT TTTTTTTACA TAAGAGCTAA 1130